Esperion Therapeutics Inc (ESPR)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché ESPR Giù? Forum Previsione Frazionamento azionario

Esperion Therapeutics Inc Azioni (ESPR) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	5.96% 65.00	69.11	51.63	73.83	137.74
Operating Expenses	18.44% 87.09	73.53	67.66	71.25	65.47
Benefits Costs and Expenses	-	-	-	-	-
Costs And Expenses	18.44% 87.09	73.53	67.66	71.25	65.47
Operating Income/Loss	399.91% -22.10	-4.42	-16.03	2.579	72.27
Income/Loss From Continuing Operations Before Tax	5.96% 65.00	69.11	51.63	-61.92	61.02
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	89.77% -40.45	-21.32	-29.52	-61.92	61.02
Net Income/Loss	89.77% -40.45	-21.32	-29.52	-61.92	61.02
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	6,866% 196.13	2.8154	194.93	188.79	169.26
Diluted Average Shares	6,866% 196.13	2.8154	194.93	188.79	189.64
Basic Earnings Per Share	90.91% -0.21	-0.11	-0.15	-0.33	0.36
Diluted Earnings Per Share	90.91% -0.21	-0.11	-0.15	-0.33	0.34
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ALKS

$29.25

0.93%

ELAN

$18.49

3.30%

RDY

$14.24

0.21%

VTRS

$10.42

0.10%

NBIX

$138.13

0.94%

UTHR

$305.35

1.25%